Allworth Financial’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Allworth Financial’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-18	Closed	-$1K	–	3268
2022 Q2	$1K	Buy	+18	New	+$800	﹤0.01%	2335

Allworth Financial's TPTX Position: Q3 2022 in Review

Allworth Financial sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 18 shares — an estimated $1K sold.

Allworth Financial first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $1K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Allworth Financial reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Allworth Financial sold 18 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1K.
Allworth Financial first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Allworth Financial's Turning Point Therapeutics, Inc. Common Stock position peaked at $1K in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Allworth Financial's 13F filing for Q3 2022, filed 18 Oct 2022.